Literature DB >> 17270091

Oxidative and nitrosative stress in acute ischaemic stroke.

Mehmet Seneş1, Nuran Kazan, Ozlem Coşkun, Oğuzhan Zengi, Levent Inan, Doğan Yücel.   

Abstract

BACKGROUND: Increased nitric oxide (NO) production may result in further brain damage via nitric oxide synthase uncoupling in patients with acute ischaemic stroke by increasing free radical formation and oxidative stress. In this connection, we measured nitrite and nitrate (NO metabolites), ischaemia-modified albumin (IMA) and thiobarbituric acid-reactive substances (TBARS) in patients with ischaemic stroke.
METHODS: We studied 41 patients with ischaemic stroke (22 men and 19 women, aged 65+/-13 years) and 37 age- and sex-matched controls (22 men and 15 women, aged 65+/-8 years). Blood samples were drawn within the first 24 h from the onset of symptoms in the patient group. Fasting morning samples were used in the control group. Concentrations of nitrite and nitrate were determined by Griess reagent; concentrations of IMA were determined by the albumin cobalt-binding test; and concentrations of TBARS were determined colorimetrically by thiobarbituric acid.
RESULTS: Nitrate, IMA and TBARS concentrations were significantly increased compared with controls (P<0.005, P<0.001, and P=0.01, respectively).
CONCLUSIONS: Patients with acute ischaemic stroke exhibit abnormalities in a range of markers of increased nitrosative and oxidative stress. These abnormalities may contribute to greater brain damage in patients with acute ischaemic stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270091     DOI: 10.1258/000456307779596057

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  19 in total

1.  Serum ischaemic-modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism.

Authors:  Varikasuvu Seshadri Reddy; P V L N Srinivasa Rao; M M Suchitra; Renu Garg
Journal:  Endocrine       Date:  2013-10-12       Impact factor: 3.633

2.  Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels.

Authors:  Mufide Oncel; Aysel Kıyıcı; Serife Onen
Journal:  J Clin Lab Anal       Date:  2014-06-21       Impact factor: 2.352

3.  Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Authors:  Aysel Kiyici; Idris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçin Solak; Süleyman Türk
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Obstructive sleep apnea and the effect of CPAP treatment on ischemia-modified albumin levels: a multi effect size meta-analysis with diagnostic test accuracy.

Authors:  Seshadri Reddy Varikasuvu; Naveen Dutt; Dibakar Sahu
Journal:  Sleep Breath       Date:  2018-06-14       Impact factor: 2.816

5.  Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

Authors:  S V Reddy; M M Suchitra; V Pradeep; S Alok; V Suresh; A R Bitla; P V L N Srinivasa Rao
Journal:  J Endocrinol Invest       Date:  2015-04-11       Impact factor: 4.256

6.  Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes.

Authors:  Meng-Hai Wu; Fang-Yu Song; Li-Ping Wei; Zhao-Yun Meng; Zhi-Qiang Zhang; Qin-De Qi
Journal:  Mol Neurobiol       Date:  2014-12-19       Impact factor: 5.590

7.  Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.

Authors:  E Cakir; M Ozbek; E Ozkaya; N Colak; E Cakal; M Sayki; A Gungunes; Y Aliyazicioglu; A Mentese; T Delibasi
Journal:  J Endocrinol Invest       Date:  2010-11-16       Impact factor: 4.256

8.  Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas.

Authors:  Teresa Stachowicz-Stencel; Anna Synakiewicz; Anna Owczarzak; Aleksandra Sliwińska; Ewa Aleksandrowicz-Wrona; Wiesawa Lysiak-Szydowska; Anna Balcerska
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

9.  Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy.

Authors:  V S Reddy; P Agrawal; S Sethi; N Gupta; R Garg; H Madaan; V Kumar
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

10.  A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.

Authors:  Kubilay Ukinc; Selcuk Eminagaoglu; Halil Onder Ersoz; Cihangir Erem; Caner Karahan; Arif Bayram Hacihasanoglu; Mustafa Kocak
Journal:  Endocrine       Date:  2009-09-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.